๐ฐ Structure Activity Relationship News
Structure Activity Relationship News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Structure Activity Relationship. Real-time updates on events, politics, business and more.
October 25, 2023
MARA will be integrated into Nanome's XR platform to save chemists' time and open new abilities for SAR analysis.
September 5, 2022
Conopeptides are peptides in the venom of marine cone snails that are used for capturing prey or as a defense against predators. A new cysteine-poor conopeptide, Czon1107, has exhibited non-competitive inhibition with an undefined allosteric mechanism in the human (h) ฮฑ3ฮฒ4 nicotinic acetylcholine receptors (nAChRs). In this study, the binding mode of Czon1107 to hฮฑ3ฮฒ4 nAChR was investigated using molecular dynamics simulations coupled with mutagenesis studies of the peptide and electrophysio...
August 2, 2022
/PRNewswire/ -- Eleven Therapeutics, a biotechnology company leading the AI revolution in nucleic acid therapeutics, announced today that it has raised a total...
April 5, 2022
Four companies have shared unpublished hazard data for drug substances to enhance database-dependent computational tools and help reduce animal testing.
February 14, 2022
Antiviral Medicinal Chemistry Postdoctoral Fellow Positions, Antiviral Program for Pandemics, Div. job in Rockville, Maryland with National Center of Advancing Translational Services. Apply Today.
October 14, 2021
Post-Doctoral candidate in medicinal chemistry job in Rockville, Maryland with National Center of Advancing Translational Services. Apply Today.
May 7, 2021
Quantitative Structure-Activity Relationship Market for Drug Discovery Segment to Grow at Highest CAGR during 2020-2027. Quantitative Structure-Activity Relationship (QSAR) Marketย is expected to reach US$ 1,888.5 million in 2027 from US$ 1,388.1 million in 2019, it is estimated to grow at a CAGR of 4.0% from 2020 to 2027. The market growth is mainly attributed to the increasing adoption rate of modeling tools in drug discovery and rising investments for drug discovery. However, low adoption ...